Search filters
Filters
Clear All

Phase

  • 54
  • 61
  • 2
  • 53
  • 1
  • 51
  • 11
  • 670
  • 926
  • 606
  • 5
  • 39
  • 886

Found 930 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Chronic Hypertension and Pregnancy (CHAP) Trial Maternal Follow-up Study

Female
This is a long-term follow up of participants enrolled in the CHAP trial during a 5-year window starting between 0-6 years until 5-10 years after their participation in the original CHAP trial. The goal is to determine whether treatment of mild CHTN in pregnancy influences maternal risk of cardiovascular disease …
Learn More

INCB039110-801

99 years and younger
All genders
The purpose of this study is to provide continued treatment with itacitinib to participants who are currently enrolled in the Parent Study of itacitinib.
Learn More

RESPIRION-102

99 years and younger
All genders
The main purpose of this study is to see whether inhaling this combination of drugs in RSP-1502 has an acceptable safety profile and works better compared to inhaling tobramycin alone when treating participants with Cystic Fibrosis and chronic Pseudomonas aeruginosa lung infection. Procedures include spirometry, ECG, sputum collection, and pharmacokinetic …
Learn More

TAP

99 years and younger
All genders
This is a prospective, multicenter, randomized, double-blind, placebo-controlled, parallel-group, large simple trial to investigate the efficacy and safety of a single intravenous (IV) infusion of BE1116 in subjects who have traumatic injury, with confirmed or suspected acute major bleeding and/or predicted to receive a large volume blood product
Learn More

UPCC 23922 A Phase II Multi-Arm (basket) Trial Investigating the Safety and Efficacy of IO102-IO103 in Combination with Pembrolizumab, as First-line Treatment for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of H

99 years and younger
All genders
A Phase II Multi-Arm (basket) Trial Investigating the Safety and Efficacy of IO102-IO103 in Combination with pembrolizumab, as First-line Treatment for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of Head or Neck (SCCHN), or Metastatic Urothelial Bladder Cancer (mUBC)
Learn More

PD DBS Sleep Study

99 years and younger
All genders
The purpose of this study is to gain a better understanding of how signals in the brain contribute to abnormal sleep behavior in patients with Parkinson's Disease (PD).
Learn More

UPCC 23423: Full Protocol Title A Phase 1b/2 Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of the Selective SYK Inhibitor Lanraplenib (LANRA) in Combination with the FLT3 Inhibitor Gilteritinib, in Patients with FLT

99 years and younger
All genders
This study tests an investigational drug called LANRA as a possible treatment for people with relapsed or refractory FLT3-mutated AML. This study will take place in 2 parts. In Part 1 (dose escalation), the main purpose is to determine the maximal dose of LANRA that can be safely administered and …
Learn More

Colchicine in PAD

99 years and younger
All genders
Please see Section 3 of the full protocol. Please see Section 3 of the full protocol. Please see Section 3 of the full protocol.
Learn More

Patent-E

99 years and younger
All genders
The primary objective of this study is to evaluate the safety and efficacy of the ProTractX3 DCB for the treatment of benign esophageal strictures. The ProTractX3 DCB is intended to treat benign strictures of the alimentary tract, combining mechanical dilation with localized delivery of the drug paclitaxel. The ProTractX3 DCB …
Learn More

Amryt METRE

99 years and younger
All genders
This is a 12-month, multicenter, randomized, double-blind, placebo-controlled Phase 3 study to evaluate the safety and efficacy of daily subcutaneous metreleptin treatment in subjects with Familial Partial Lipodystrophy (FPLD). Subjects will be assigned to 1 of 3 groups depending on HbA1c and fasting TGs levels. Participants will complete 10 visits …
Learn More
571 - 580 of 930